Wayfinder Biosciences Embarks on New Phase with Daiichi Sankyo to Tackle Neurodegeneration Challenges Wayfinder Biosciences is advancing its collaboration with Daiichi Sankyo to develop small molecules targeting neurodegeneration, marking a significant research milestone.

Wayfinder Biosciences Embarks on New Phase with Daiichi Sankyo to Tackle Neurodegeneration Challenges #USA #Seattle #Daiichi_Sankyo #Wayfinder_Biosciences #RNA-targeting_drugs

Wayfinder Biosciences and Daiichi Sankyo Join Forces for Innovative RNA-Targeting Therapies Wayfinder Biosciences teams up with Daiichi Sankyo to develop innovative RNA-targeting treatments for neurodegenerative diseases, promising new hope.

Wayfinder Biosciences and Daiichi Sankyo Join Forces for Innovative RNA-Targeting Therapies #USA #Seattle #Daiichi_Sankyo #Wayfinder_Biosciences #RNA_Therapy